Somany Ceramics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 9:31 am

Competitors of Somany Ceramics Ltd

All Competitor Stocks of Somany Ceramics Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:20 am

Below is a detailed analysis of the quarterly data for Somany Ceramics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 604.44 Cr.. The value appears to be declining and may need further review. It has decreased from 768.99 Cr. (Mar 2025) to 604.44 Cr., marking a decrease of 164.55 Cr..
• For Expenses, as of Jun 2025, the value is 556.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 706.53 Cr. (Mar 2025) to 556.26 Cr., marking a decrease of 150.27 Cr..
• For Operating Profit, as of Jun 2025, the value is 48.18 Cr.. The value appears to be declining and may need further review. It has decreased from 62.46 Cr. (Mar 2025) to 48.18 Cr., marking a decrease of 14.28 Cr..
• For OPM %, as of Jun 2025, the value is 7.97%. The value appears to be declining and may need further review. It has decreased from 8.12% (Mar 2025) to 7.97%, marking a decrease of 0.15%.
• For Other Income, as of Jun 2025, the value is 1.90 Cr.. The value appears to be declining and may need further review. It has decreased from 3.79 Cr. (Mar 2025) to 1.90 Cr., marking a decrease of 1.89 Cr..
• For Interest, as of Jun 2025, the value is 12.71 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.18 Cr. (Mar 2025) to 12.71 Cr., marking an increase of 0.53 Cr..
• For Depreciation, as of Jun 2025, the value is 25.98 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 29.11 Cr. (Mar 2025) to 25.98 Cr., marking a decrease of 3.13 Cr..
• For Profit before tax, as of Jun 2025, the value is 11.39 Cr.. The value appears to be declining and may need further review. It has decreased from 24.96 Cr. (Mar 2025) to 11.39 Cr., marking a decrease of 13.57 Cr..
• For Tax %, as of Jun 2025, the value is 35.47%. The value appears to be increasing, which may not be favorable. It has increased from 25.04% (Mar 2025) to 35.47%, marking an increase of 10.43%.
• For Net Profit, as of Jun 2025, the value is 7.35 Cr.. The value appears to be declining and may need further review. It has decreased from 18.71 Cr. (Mar 2025) to 7.35 Cr., marking a decrease of 11.36 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.53. The value appears to be declining and may need further review. It has decreased from 5.20 (Mar 2025) to 2.53, marking a decrease of 2.67.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:25 am

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: November 9, 2025, 2:59 pm

Below is a detailed analysis of the balance sheet data for Somany Ceramics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Reserves, as of Sep 2025, the value is 777.00 Cr.. The value appears strong and on an upward trend. It has increased from 763.00 Cr. (Mar 2025) to 777.00 Cr., marking an increase of 14.00 Cr..
• For Borrowings, as of Sep 2025, the value is 327.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 360.00 Cr. (Mar 2025) to 327.00 Cr., marking a decrease of 33.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 791.00 Cr.. The value appears to be improving (decreasing). It has decreased from 825.00 Cr. (Mar 2025) to 791.00 Cr., marking a decrease of 34.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,903.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,957.00 Cr. (Mar 2025) to 1,903.00 Cr., marking a decrease of 54.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,048.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,063.00 Cr. (Mar 2025) to 1,048.00 Cr., marking a decrease of 15.00 Cr..
• For CWIP, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
• For Investments, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
• For Other Assets, as of Sep 2025, the value is 823.00 Cr.. The value appears to be declining and may need further review. It has decreased from 861.00 Cr. (Mar 2025) to 823.00 Cr., marking a decrease of 38.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,903.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,957.00 Cr. (Mar 2025) to 1,903.00 Cr., marking a decrease of 54.00 Cr..

Notably, the Reserves (777.00 Cr.) exceed the Borrowings (327.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Somany Ceramics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 23.00 (Mar 24) to 14.65, marking a decrease of 8.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 22.98 (Mar 24) to 14.65, marking a decrease of 8.33.
• For Cash EPS (Rs.), as of Mar 25, the value is 36.15. This value is within the healthy range. It has decreased from 41.92 (Mar 24) to 36.15, marking a decrease of 5.77.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.17. It has decreased from 203.14 (Mar 24) to 188.17, marking a decrease of 14.97.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 188.17. It has decreased from 203.14 (Mar 24) to 188.17, marking a decrease of 14.97.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 648.33. It has increased from 631.98 (Mar 24) to 648.33, marking an increase of 16.35.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 56.06. This value is within the healthy range. It has decreased from 64.34 (Mar 24) to 56.06, marking a decrease of 8.28.
• For PBIT / Share (Rs.), as of Mar 25, the value is 34.05. This value is within the healthy range. It has decreased from 46.66 (Mar 24) to 34.05, marking a decrease of 12.61.
• For PBT / Share (Rs.), as of Mar 25, the value is 20.78. This value is within the healthy range. It has decreased from 34.83 (Mar 24) to 20.78, marking a decrease of 14.05.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 14.14. This value is within the healthy range. It has decreased from 24.24 (Mar 24) to 14.14, marking a decrease of 10.10.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 23.63 (Mar 24) to 14.65, marking a decrease of 8.98.
• For PBDIT Margin (%), as of Mar 25, the value is 8.64. This value is below the healthy minimum of 10. It has decreased from 10.18 (Mar 24) to 8.64, marking a decrease of 1.54.
• For PBIT Margin (%), as of Mar 25, the value is 5.25. This value is below the healthy minimum of 10. It has decreased from 7.38 (Mar 24) to 5.25, marking a decrease of 2.13.
• For PBT Margin (%), as of Mar 25, the value is 3.20. This value is below the healthy minimum of 10. It has decreased from 5.51 (Mar 24) to 3.20, marking a decrease of 2.31.
• For Net Profit Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 5. It has decreased from 3.83 (Mar 24) to 2.18, marking a decrease of 1.65.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.25. This value is below the healthy minimum of 8. It has decreased from 3.73 (Mar 24) to 2.25, marking a decrease of 1.48.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.78. This value is below the healthy minimum of 15. It has decreased from 13.45 (Mar 24) to 7.78, marking a decrease of 5.67.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.32. This value is within the healthy range. It has decreased from 16.75 (Mar 24) to 12.32, marking a decrease of 4.43.
• For Return On Assets (%), as of Mar 25, the value is 3.05. This value is below the healthy minimum of 5. It has decreased from 4.88 (Mar 24) to 3.05, marking a decrease of 1.83.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.19, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. It has decreased from 0.46 (Mar 24) to 0.39, marking a decrease of 0.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.35. It has increased from 1.30 (Mar 24) to 1.35, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has increased from 0.97 (Mar 24) to 1.01, marking an increase of 0.04.
• For Quick Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 24) to 0.60, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.77. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 7.77, marking an increase of 6.30.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.47. This value is within the healthy range. It has increased from 13.15 (Mar 24) to 20.47, marking an increase of 7.32.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.18. This value is below the healthy minimum of 20. It has increased from 7.52 (Mar 24) to 8.18, marking an increase of 0.66.
• For Earning Retention Ratio (%), as of Mar 25, the value is 79.53. This value exceeds the healthy maximum of 70. It has decreased from 86.85 (Mar 24) to 79.53, marking a decrease of 7.32.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.82. This value exceeds the healthy maximum of 70. It has decreased from 92.48 (Mar 24) to 91.82, marking a decrease of 0.66.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.38. This value is within the healthy range. It has decreased from 5.68 (Mar 24) to 4.38, marking a decrease of 1.30.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 3. It has decreased from 3.18 (Mar 24) to 2.14, marking a decrease of 1.04.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,019.65. It has decreased from 2,740.48 (Mar 24) to 2,019.65, marking a decrease of 720.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.75, marking a decrease of 0.31.
• For EV / EBITDA (X), as of Mar 25, the value is 8.78. This value is within the healthy range. It has decreased from 10.39 (Mar 24) to 8.78, marking a decrease of 1.61.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.64, marking a decrease of 0.27.
• For Retention Ratios (%), as of Mar 25, the value is 79.52. This value exceeds the healthy maximum of 70. It has decreased from 86.84 (Mar 24) to 79.52, marking a decrease of 7.32.
• For Price / BV (X), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 3.28 (Mar 24) to 2.23, marking a decrease of 1.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.91 (Mar 24) to 0.64, marking a decrease of 0.27.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness